Skip to main content
. 2016 Mar 2;12:559–569. doi: 10.2147/NDT.S98511

Table 1.

Demographic and baseline characteristics of the intention-to-treat study population (n=53)

Characteristic All patients (n=53)
Age, years 83.0±5.9
>80 years, n (%) 34 (64.1)
Females/males, n (%) 35/18 (66.0/34.0)
Pain intensity
 NRS 6.6±1.0
 PAINAD 6.9±1.6
Severe pain,a n (%) 29 (54.7)
 Nociceptive 47 (88.7)
 Mixed 3 (5.6)
 Neuropathic, peripheral 2 (3.8)
 Neuropathic, central 1 (1.9)
Cause of pain, n (%)
 Osteoarthritis 25 (47.2)
 Bone fractures 19 (35.8)
 Arthroplasty 6 (11.3)
 Diabetic polyneuropathy 2 (3.8)
 Stroke 1 (1.9)
Analgesic therapy, n (%)
 No analgesics 22 (41.5)
 Acetaminophen 18 (34.0)
 NSAIDs 7 (13.2)
 Codeine 3 (5.6)
 Tramadol 3 (5.6)
Adjuvants, n (%) 18 (34.0)
Rescue analgesics,b n (%) 17 (32.1)
MMSE 18.6±3.0
NPI 25.5±27.3
Barthel index 32.2±16.8
CIRS-G Severity Index 2.1±0.7
CIRS-G Comorbidity Index 3.9±1.7
BFI 25.6±19.7
Use of laxatives, n (%) 21 (39.6)

Notes: All values are expressed as mean ± standard deviation or n (%).

a

Severe pain defined by NRS or PAINAD score >6.

b

Oral acetaminophen, 500–1,000 mg, taken in addition to current analgesics.

Abbreviations: BFI, Bowel Function Index; CIRS-G, Cumulative Illness Rating Scale-Geriatric version; MMSE, Mini-Mental State Examination; NPI, Neuropsychiatric Inventory; NRS, numerical rating scale; PAINAD, Pain Assessment in Advanced Dementia; NSAIDs, nonsteroidal anti-inflammatory drugs.